Heparin Sodium And Dextrose
NDC Package 0409-7793-23

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Heparin Sodium And Dextrose is heparin sodium is indicated for:    Atrial fibrillation with embolization;    Treatment of acute and chronic consumption coagulopathies (disseminated intravascular coagulation);    Prevention of clotting in arterial and heart surgery;    Prophylaxis and treatment of peripheral arterial embolism;    As an anticoagulant in extracorporeal arterial circulation and dialysis procedures. Marketed by Hospira, Inc., this product is identified by NDC 0409-7793 and is authorized under FDA application NDA019339.

Identification & Billing

NDC Package Code
0409-7793-23
Package Description
24 POUCH in 1 CASE / 1 BAG in 1 POUCH / 100 mL in 1 BAG (0409-7793-13)
Product Code
0409-7793
11-Digit Billing Format
00409779323
RxNorm Crosswalk
  • RxCUI: 1658717 - heparin sodium, porcine 25,000 UNT in 250 ML Injection
  • RxCUI: 1658717 - 250 ML heparin sodium, porcine 100 UNT/ML Injection
  • RxCUI: 1658717 - heparin sodium, porcine 25,000 UNT per 250 ML Injection

Clinical Specifications

Proprietary Name
Heparin Sodium And Dextrose
Dosage Form
-
Usage Information
Heparin sodium is indicated for:    Atrial fibrillation with embolization;    Treatment of acute and chronic consumption coagulopathies (disseminated intravascular coagulation);    Prevention of clotting in arterial and heart surgery;    Prophylaxis and treatment of peripheral arterial embolism;    As an anticoagulant in extracorporeal arterial circulation and dialysis procedures.

Regulatory & Marketing

Labeler Name
Hospira, Inc.
FDA Application #
NDA019339
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
10-25-2005
End Marketing Date
12-01-2024
Listing Expiration
12-01-2024
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0409-7793). Click a package code to view its specific billing and regulatory data.

0409-7793-62
24 POUCH in 1 CASE / 1 BAG in 1 POUCH / 250 mL in 1 BAG (0409-7793-52)

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0409-7793-23 identifies a specific commercial package of 24 pouch in 1 case / 1 bag in 1 pouch / 100 ml in 1 bag (0409-7793-13) of Heparin Sodium And Dextrose, labeled by Hospira, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Hospira, Inc. on October 25, 2005. The current certification is valid through December 01, 2024.

How is this Hospira, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00409779323. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0409-7793-23
11-Digit CMS (5-4-2)
00409-7793-23

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.